KospicyKorean filings in English
Filings / Medy-Tox

Preliminary Consolidated Operating Results (Fair Disclosure)

Medy-Tox · 연결재무제표기준영업(잠정)실적(공정공시)

8-KKOSDAQ · 086900 Filed 2026-11-10Korean original on DART

English form view 63% translated

Translated from a fixed dictionaryLeft in Korean (free text, names)Numbers and dates are copied unchanged

Preliminary consolidated operating results (Fair Disclosure)

Results Period
Current Period Results2026-07-01~2026-09-30
Prior Period Results2026-04-01~2026-06-30
Prior-Year Same Period Results2025-07-01~2025-09-30
Current Period Cumulative Results2026-01-01~2026-09-30
Prior-Year Same Period Cumulative Results2025-01-01~2025-09-30
※ This information is preliminary, not final, and may differ from final figures.
1. Consolidated results
Category (Unit: KRW m, %)Current Period ResultsPrior Period Resultsvs. Prior PeriodPrior-Year Same Period ResultsYoY
(2026.3Q)(2026.2Q)Change (%)Profit/loss turnaround(2025.3Q )Change (%)Profit/loss turnaround
RevenueCurrent Results59,31568,702-13.7-61,017-2.8-
Cumulative Results188,705---186,6211.1-
Operating IncomeCurrent Results15,5314,765225.9-8,89974.5-
Cumulative Results27,668---20,69333.7-
Income from continuing operations before income taxCurrent Results13,7414,259222.6-7,78076.6-
Cumulative Results27,702---20,56634.7-
Net IncomeCurrent Results11,6163,128271.4-7,19961.4-
Cumulative Results22,623---18,71620.9-
Net income attributable to owners of the parentCurrent Results11,5723,107272.4-7,43455.7-
Cumulative Results22,475---19,61214.6-
--------
2. Information ProvidedInformation Provider(주)메디톡스
Information Recipient국내외 정보이용자
Information release date (scheduled)공정공시 후 투자자제공
Information release time (scheduled)-
Event Name (Venue)-
3. ContactChief Disclosure Officer (Name)신효진
Chief Disclosure Officer (Phone)02-3471-8319
Disclosure Officer (Name)김웅규
Disclosure Officer (Phone)02-3471-8319
Department NameIR Team
Department (Phone)02-6901-5871
4. Other Matters Relevant to Investment Decisions1) 상기 실적자료는 한국채택국제회계기준(K-IFRS)에 따라 작성된 연결기준 영업(잠정) 실적입니다. 2) 상기 실적은 외부감사인의 회계검토가 완료되지 않은 상태에서 투자자 편의를 위해 작성된 것으로 회계검토과정에서 변경될 수 있습니다. 3) 기타 자세한 사항은 당사 홈페이지(https://www.medytox.com)를 참조하시기 바랍니다.
※ Related Disclosures-